GlycanAge
A commercial biological-age test based on the glycosylation pattern of IgG antibodies — it grew out of real research from the Croatian Genos/Gordan Lauc group, but independent validation of the product itself remains limited.
Number of studies
3
Safety
High
Time to effects
This is a measurement, not an intervention — in intervention studies, noticeable changes in the score after weight loss were reported after several months to a year, not immediately.
Who it's for
Table of contents
TL;DR
A commercial biological-age test based on the glycosylation pattern of IgG antibodies — it grew out of real research from the Croatian Genos/Gordan Lauc group, but independent validation of the product itself remains limited.
- →A synthetic, single-number index combining multiple aspects of the IgG glycosylation profile into one score
- →In intervention studies the score responded to substantial weight loss, suggesting it is modifiable
- →Mechanistically grounded in a well-described biological phenomenon (age-related change in the IgG glycome) rather than a purely statistical correlation
| Type of tool | Commercial biological-age test + research concept (IgG glycome) |
|---|---|
| What it measures | Glycosylation profile of IgG antibodies (galactosylation, sialylation, bisecting GlcNAc) |
| Where the concept comes from | Genos Glycobiology Laboratory, Zagreb (Gordan Lauc's team), 2014 study |
| Heritability of the index | About 39% on average — most of the variance is environmental |
| Mechanistic link | Reflects the intensity of inflammaging (chronic inflammation) |
| Research level | Preliminary — solid data from the originating group, limited independent replication |
| Status | Direct-to-consumer test, outside standard medical diagnostics |
Understand
Overview
GlycanAge is the name of a commercial biological-age test, but it's also a broader research concept referring to the analysis of IgG (immunoglobulin G) glycosylation as a marker of aging. The foundation of this concept is the work of Jasminka Krištić and Gordan Lauc's team at the Genos Glycobiology Laboratory in Zagreb, published in 2014 — it showed that the complex sugar profile attached to the Fc fragment of IgG antibodies (the IgG glycome) correlates both with chronological age (explaining a substantial share of its variance in that study) and with physiological parameters typical of biological aging, independent of chronological age itself.
The link to inflammaging (see the separate entry) is key here: with age, the IgG glycan profile shifts toward more pro-inflammatory forms — galactosylation and sialylation decrease while bisecting GlcNAc increases — which corresponds to a greater readiness of antibodies to activate the complement system and Fcγ receptors, and thus to a general intensification of the chronic, low-grade inflammation characteristic of aging. The IgG glycome is therefore sometimes treated as an indirect readout of this phenomenon, compressed into a single synthetic number.
Who can realistically benefit from this? People interested in commercial biological-age tests who want to track, over time, how lifestyle changes (e.g., weight loss) affect one aggregated indicator. It's worth remembering, though, that GlycanAge as a commercial product has not yet undergone broad, independent validation outside the research group that developed it — and the heritability of the index is estimated at around 39% on average, meaning most of its variability comes from environmental and behavioral factors rather than genes. That's potentially good news for how modifiable the score is, but it's also a reminder that this is not a test with the clinical validation of, say, a basic blood count.
Mechanism of action
IgG is an antibody whose Fc fragment (responsible for interacting with the immune system, not for antigen recognition) always carries an attached sugar chain (N-glycan) at a conserved site. The composition of this chain — the presence or absence of galactose, sialic acid, fucose, and a so-called bisecting GlcNAc residue — determines how strongly a given antibody activates the complement system and Fcγ receptors on immune cells. Agalactosylated forms (lacking a terminal galactose, labeled G0) are associated with stronger activation of pro-inflammatory pathways, while fully galactosylated and sialylated forms tend to have a more anti-inflammatory effect.
With age, the proportions of these forms shift systematically toward a pro-inflammatory profile — a phenomenon observed in large human cohorts and used to build the 'glycan clock' algorithm, which calculates one aggregated score from the full glycoform profile of IgG. Intervention studies (substantial weight loss following a low-calorie diet or bariatric surgery) have shown a partial reversal of this pro-inflammatory glycome shift over a timeframe of months to a year, suggesting the index isn't static and responds to physiological change — though the mechanism linking body weight to IgG glycome composition isn't fully explained.
IgG glycosylation in the Golgi apparatus
Every IgG molecule receives a sugar chain attached during synthesis at a fixed site on the Fc fragment.
Shift in glycoform profile with age
The share of fully galactosylated and sialylated forms declines while the share of pro-inflammatory (agalactosylated, bisected) forms rises.
Effect on antibody immune activity
The altered sugar profile affects binding strength to Fcγ receptors and the complement system, shifting the balance toward pro-inflammatory.
Calculating the aggregated index
An algorithm combines the proportions of individual glycoforms into a single score compared against the population distribution for a given age.
Evidence: early-stage — based on 3 studies in this database.
Benefits
Common myths
MythGlycanAge is a clinically validated medical test, comparable to a blood count.
FactIt's a commercial wellness test sold direct-to-consumer — the underlying science (the IgG glycome) is real, but the product itself has not yet undergone broad, independent clinical validation outside the research group that developed it.
MythThe GlycanAge result is largely genetically determined and hard to change.
FactThe estimated heritability of the index is about 39% on average — most of its variability comes from environmental and behavioral factors, which in intervention studies translated into noticeable changes after weight loss.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
The two approaches measure a different level of biology — epigenetic clocks analyze DNA methylation patterns, while GlycanAge analyzes the sugar structures attached to IgG antibodies. These are distinct, partially age-related biological signals rather than two measurements of the same thing, which is why they're sometimes treated as complementary pieces of a bigger picture rather than substitutes.
There's no direct human evidence for that — available studies show a correlation between the glycan profile and age and physiological parameters, not hard data on translating into lifespan from prospective cohort studies with hard endpoints.
In intervention studies, the largest documented effect came from substantial weight loss. The role of individual supplements or short-term lifestyle changes on the result hasn't been solidly studied yet.
Available analytical data point to reasonable measurement precision between repeats, while between-person variability over time and the impact of short-term factors (e.g., a transient infection) are still under study.
What to combine with
Good combinations
Mediterranean Diet — Interventions that reduced body weight were linked in studies to a favorable shift in the IgG glycan profile
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Is it worth taking?
Who it's for
- People interested in commercial biological-age tests who are aware of the limits of their independent validation
- People who want to track how weight or lifestyle changes affect one aggregated pro-inflammatory index over time
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
The foundational 2014 study (Krištić et al.) showed a strong link between the IgG glycan profile and both chronological and biological age.
Substantial weight loss (low-calorie diet, bariatric surgery) was linked in a 2021 study to a reduction in the calculated glycan age.
The index's heritability is estimated at about 39% on average, pointing to a large role for environmental factors.
Studies
Glycans Are a Novel Biomarker of Chronological and Biological Ages
Moderate evidenceKrištić J, Vučković F, Menni C, et al. · The Journals of Gerontology: Series A · 2014
A foundational study in large human cohorts showing that the IgG glycan profile correlates with both chronological age and physiological parameters typical of biological aging.
View studyExtensive weight loss reduces glycan age by altering IgG N-glycosylation
Early-stage evidenceGreto VL, Cvetko A, Štambuk T, et al. · International Journal of Obesity · 2021
An intervention study (low-calorie diet and bariatric surgery) showing that substantial weight loss is linked to a reduction in the calculated glycan age over a year-long follow-up.
View studyHeritability of the glycan clock of biological age
Early-stage evidenceMijakovac A, Frkatović A, Hanić M, et al. · Frontiers in Cell and Developmental Biology · 2022
An analysis estimating the average heritability of the glycan clock at about 39%, suggesting a substantial role for environmental factors in shaping the result.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.
121 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
174 publications on this site
Related entries
4.2Biological Age Clocks
An umbrella term covering very different methods for estimating the 'true' pace at which an organism is aging — from well-validated second-generation epigenetic clocks to far less proven commercial tests based on glycans or the microbiome. Not all of them carry a comparable level of evidence.
4.1Epigenetic Age Acceleration
The difference between an age estimated from a DNA methylation pattern and chronological age — one of the most statistically well-documented aging biomarkers, strongly linked to mortality in population studies, though still of limited diagnostic value for a single individual.
4.2Organ Biological Age
The concept that individual organs — the heart, brain, liver, or kidneys — can age at markedly different rates within the same person, measurable through analysis of tissue-specific plasma proteins rather than a single, averaged 'biological age' score.
4.3Inflammaging
Chronic, low-grade, systemic inflammation that accompanies aging even without an active infection — a term coined in 2000 by Claudio Franceschi, today considered one of the fundamental mechanisms linking aging to age-related disease.
4.0OMAA Score
The OMAA Score (Oral Microbiome Aging Acceleration) is a numerical index calculated as the difference between the age predicted from an oral microbiome sample and a person's actual age — in the study that introduced it, it was linked to elevated mortality and frailty risk.
3.9MicroAge
A machine-learning model that estimates biological age from the composition of the saliva microbiome — a very early, emerging approach to aging biomarkers, distinct from the mortality-focused OMAA Score.
4.1Oral Microbiome Aging
The composition of bacteria colonizing the mouth changes in a predictable way with age — predictable enough that researchers have started building models to estimate biological age from a simple saliva sample.
4.7HbA1c (Glycated Hemoglobin)
A biomarker reflecting average blood glucose over the past 2–3 months — the gold standard for diagnosing and monitoring diabetes, far more stable than a single glucose measurement.
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.